You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 43 Issue 5

March 2016

Volume 43, Issue 5

Pages 549–661

  1. SYSTEMATIC REVIEWS WITH META-ANALYSES

    1. Top of page
    2. SYSTEMATIC REVIEWS WITH META-ANALYSES
    3. EPISODIC DIARRHOEA
    4. VOLATILE METABOLITES FOR IBD DIAGNOSIS
    5. PROGNOSIS IN PRIMARY SCLEROSING CHOLANGITIS
    6. HEPATOCELLULAR CARCINOMA
    7. NON-ALCOHOLIC FATTY LIVER DISEASE
    8. INVITED EDITORIALS
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
      Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis (pages 562–574)

      O. J. Kennedy, P. Roderick, R. Buchanan, J. A. Fallowfield, P. C. Hayes and J. Parkes

      Article first published online: 25 JAN 2016 | DOI: 10.1111/apt.13523

    3. You have free access to this content
  2. EPISODIC DIARRHOEA

    1. Top of page
    2. SYSTEMATIC REVIEWS WITH META-ANALYSES
    3. EPISODIC DIARRHOEA
    4. VOLATILE METABOLITES FOR IBD DIAGNOSIS
    5. PROGNOSIS IN PRIMARY SCLEROSING CHOLANGITIS
    6. HEPATOCELLULAR CARCINOMA
    7. NON-ALCOHOLIC FATTY LIVER DISEASE
    8. INVITED EDITORIALS
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
  3. VOLATILE METABOLITES FOR IBD DIAGNOSIS

    1. Top of page
    2. SYSTEMATIC REVIEWS WITH META-ANALYSES
    3. EPISODIC DIARRHOEA
    4. VOLATILE METABOLITES FOR IBD DIAGNOSIS
    5. PROGNOSIS IN PRIMARY SCLEROSING CHOLANGITIS
    6. HEPATOCELLULAR CARCINOMA
    7. NON-ALCOHOLIC FATTY LIVER DISEASE
    8. INVITED EDITORIALS
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
  4. PROGNOSIS IN PRIMARY SCLEROSING CHOLANGITIS

    1. Top of page
    2. SYSTEMATIC REVIEWS WITH META-ANALYSES
    3. EPISODIC DIARRHOEA
    4. VOLATILE METABOLITES FOR IBD DIAGNOSIS
    5. PROGNOSIS IN PRIMARY SCLEROSING CHOLANGITIS
    6. HEPATOCELLULAR CARCINOMA
    7. NON-ALCOHOLIC FATTY LIVER DISEASE
    8. INVITED EDITORIALS
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
  5. HEPATOCELLULAR CARCINOMA

    1. Top of page
    2. SYSTEMATIC REVIEWS WITH META-ANALYSES
    3. EPISODIC DIARRHOEA
    4. VOLATILE METABOLITES FOR IBD DIAGNOSIS
    5. PROGNOSIS IN PRIMARY SCLEROSING CHOLANGITIS
    6. HEPATOCELLULAR CARCINOMA
    7. NON-ALCOHOLIC FATTY LIVER DISEASE
    8. INVITED EDITORIALS
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
      Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer (pages 621–630)

      M. Walker, H. B. El-Serag, Y. Sada, S. Mittal, J. Ying, Z. Duan, P. Richardson, J. A. Davila and F. Kanwal

      Article first published online: 19 JAN 2016 | DOI: 10.1111/apt.13505

  6. NON-ALCOHOLIC FATTY LIVER DISEASE

    1. Top of page
    2. SYSTEMATIC REVIEWS WITH META-ANALYSES
    3. EPISODIC DIARRHOEA
    4. VOLATILE METABOLITES FOR IBD DIAGNOSIS
    5. PROGNOSIS IN PRIMARY SCLEROSING CHOLANGITIS
    6. HEPATOCELLULAR CARCINOMA
    7. NON-ALCOHOLIC FATTY LIVER DISEASE
    8. INVITED EDITORIALS
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
      I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders (pages 631–642)

      M.-F. Xia, Y. Ling, H. Bian, H.-D. Lin, H.-M. Yan, X.-X. Chang, X.-M. Li, H. Ma, D. Wang, L.-S. Zhang, S.-S. Wang, B.-J. Wu, W.-Y. He, N.-Q. Zhao and X. Gao

      Article first published online: 13 JAN 2016 | DOI: 10.1111/apt.13521

  7. INVITED EDITORIALS

    1. Top of page
    2. SYSTEMATIC REVIEWS WITH META-ANALYSES
    3. EPISODIC DIARRHOEA
    4. VOLATILE METABOLITES FOR IBD DIAGNOSIS
    5. PROGNOSIS IN PRIMARY SCLEROSING CHOLANGITIS
    6. HEPATOCELLULAR CARCINOMA
    7. NON-ALCOHOLIC FATTY LIVER DISEASE
    8. INVITED EDITORIALS
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
    8. You have free access to this content
    9. You have free access to this content
  8. LETTERS TO THE EDITORS

    1. Top of page
    2. SYSTEMATIC REVIEWS WITH META-ANALYSES
    3. EPISODIC DIARRHOEA
    4. VOLATILE METABOLITES FOR IBD DIAGNOSIS
    5. PROGNOSIS IN PRIMARY SCLEROSING CHOLANGITIS
    6. HEPATOCELLULAR CARCINOMA
    7. NON-ALCOHOLIC FATTY LIVER DISEASE
    8. INVITED EDITORIALS
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
      Letter: effectiveness of golimumab to induce remission in outpatient ulcerative colitis in Italy (pages 657–658)

      A. Tursi, N. Della Valle, A. Penna, G. Pranzo, C. Ricciardelli and M. Picchio

      Article first published online: 3 FEB 2016 | DOI: 10.1111/apt.13509

    6. You have free access to this content
    7. You have free access to this content
    8. You have free access to this content

SEARCH

SEARCH BY CITATION